Anaphylaxis and mast cell disease: What is the risk?

Current Allergy and Asthma Reports

Volumn 10, Issue 1, 2010, Pages 34-38

  Akin, Cem ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anaphylaxis; C kit; Mast cells; Mastocytosis

Indexed keywords

IMMUNOGLOBULIN E; STEM CELL FACTOR RECEPTOR;

ANAPHYLAXIS; CARDIOVASCULAR DISEASE; CELL CLONE; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HYPOTENSION; IMMUNOPATHOGENESIS; MAST CELL; MASTOCYTOSIS; REVIEW; SIGNAL TRANSDUCTION; SYNCOPE; SYSTEMIC MASTOCYTOSIS; URTICARIA;

ANAPHYLAXIS; ANIMALS; ARTHROPOD VENOMS; HUMANS; HYMENOPTERA; HYPOTENSION; INSECT BITES AND STINGS; MAST CELLS; MASTOCYTOSIS; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; RISK; SYNCOPE; URTICARIA;

EID: 76649123102     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-009-0080-8     Document Type: Review

References (39)

1. C Akin DD Metcalfe 2004 Systemic mastocytosis Annu Rev Med 55 419 432 10.1146/annurev.med.55.091902.103822 1:CAS:528:DC%2BD2cXitVWrurc%3D 14746529 (Pubitemid 38316735)
2. MC Carter DD Metcalfe 2002 Paediatric mastocytosis Arch Dis Child 86 315 319 10.1136/adc.86.5.315 1:STN:280:DC%2BD383jtFKjtw%3D%3D 11970917 (Pubitemid 34478221)
3. K Wolff M Komar P Petzelbauer 2001 Clinical and histopathological aspects of cutaneous mastocytosis Leuk Res 25 519 528 10.1016/S0145-2126(01)00044-3 1:STN:280:DC%2BD3M3pslymsg%3D%3D 11377676 (Pubitemid 32506758)
4. P Valent H Horny L Escribano, et al. 2001 Diagnostic criteria and classification of mastocytosis: a consensus proposal Leuk Res 25 603 625 10.1016/S0145-2126(01)00038-8 1:STN:280:DC%2BD3M3pslylsg%3D%3D 11377686 (Pubitemid 32506768)
5. P Valent C Akin WR Sperr, et al. 2003 Mast cell proliferative disorders: current view on variants recognized by the World Health Organization Hematol Oncol Clin North Am 17 1227 1241 10.1016/S0889-8588(03)00089-3 14560784 (Pubitemid 37187806)
6. L Escribano I Alvarez-Twose L Sanchez-Munoz, et al. 2009 Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients J Allergy Clin Immunol 124 514 521 10.1016/j.jaci.2009.05.003 19541349
7. P Valent C Akin WR Sperr, et al. 2003 Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria Leuk Res 27 635 641 10.1016/S0145-2126(02)00168-6 1:CAS:528: DC%2BD3sXis12htbs%3D 12681363 (Pubitemid 36398099)
8. C Akin DD Metcalfe 2004 The biology of Kit in disease and the application of pharmacogenetics J Allergy Clin Immunol 114 13 19 10.1016/j.jaci.2004.04.046 1:CAS:528:DC%2BD2cXlsVaqtL0%3D 15241338 quiz 20 (Pubitemid 39005112)
9. H Nagata AS Worobec CK Oh, et al. 1995 Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder Proc Natl Acad Sci U S A 92 10560 10564 10.1073/pnas.92.23.10560 1:CAS:528:DyaK2MXptlSjt70%3D 7479840
10. BJ Longley L Tyrrell SZ Lu, et al. 1996 Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm Nat Genet 12 312 314 10.1038/ng0396-312 1:CAS:528:DyaK28XhvVSgtb8%3D 8589724 (Pubitemid 26080092)
11. C Tkaczyk V Horejsi S Iwaki, et al. 2004 NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation Blood 104 207 214 10.1182/blood-2003-08-2769 1:CAS:528:DC%2BD2cXlslWgsLY%3D 15010370 (Pubitemid 38879859)
12. C Akin AS Kirshenbaum T Semere, et al. 2000 Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis Exp Hematol 28 140 147 10.1016/S0301-472X(99)00145-9 1:CAS:528:DC%2BD3cXhvVyiu7k%3D 10706069 (Pubitemid 30100820)
13. AS Yavuz PE Lipsky S Yavuz, et al. 2002 Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene Blood 100 661 665 10.1182/blood-2002-01- 0203 1:CAS:528:DC%2BD38XlsVWgtbo%3D 12091362 (Pubitemid 34761133)
14. C Akin 2005 Clonality and molecular pathogenesis of mastocytosis Acta Haematol 114 61 69 10.1159/000085563 1:CAS:528:DC%2BD2MXlvVSgtLg%3D 15995326 (Pubitemid 40911573)
15. L Escribano A Orfao B Diaz-Agustin, et al. 1998 Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications Blood 91 2731 2736 1:CAS:528: DyaK1cXisVWltL4%3D 9531582 (Pubitemid 28227522)
16. L Escribano B Diaz-Agustin C Bellas, et al. 2001 Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis Leuk Res 25 563 570 10.1016/S0145-2126(01)00050-9 1:STN:280:DC%2BD3M3pslymtw%3D%3D 11377681 (Pubitemid 32506763)
17. WR Sperr L Escribano JH Jordan, et al. 2001 Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis Leuk Res 25 529 536 10.1016/S0145-2126(01) 00041-8 1:STN:280:DC%2BD3M3pslymsw%3D%3D 11377677 (Pubitemid 32506759)
18. HP Horny MR Parwaresch K Lennert 1985 Bone marrow findings in systemic mastocytosis Hum Pathol 16 808 814 10.1016/S0046-8177(85)80252-5 1:STN:280:DyaL2M3lvFGqsQ%3D%3D 3860469
19. LB Schwartz K Sakai TR Bradford, et al. 1995 The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis J Clin Invest 96 2702 2710 10.1172/JCI118337 1:STN:280:DyaK283pt1aqtw%3D%3D 8675637
20. LB Schwartz 2006 Diagnostic value of tryptase in anaphylaxis and mastocytosis Immunol Allergy Clin North Am 26 451 463 10.1016/j.iac.2006.05.010 16931288 (Pubitemid 44247540)
21. JH Butterfield 2006 Systemic mastocytosis: clinical manifestations and differential diagnosis Immunol Allergy Clin North Am 26 487 513 10.1016/j.iac.2006.05.006 16931290 (Pubitemid 44247536)
22. M Castells 2006 Mast cell mediators in allergic inflammation and mastocytosis Immunol Allergy Clin North Am 26 465 485 10.1016/j.iac.2006.05.005 16931289 (Pubitemid 44255875)
23. M Greenhawt C Akin 2007 Mastocytosis and allergy Curr Opin Allergy Clin Immunol 7 387 392 10.1097/ACI.0b013e3282a6443e 17873577 (Pubitemid 47415281)
24. K Brockow C Jofer H Behrendt J Ring 2008 Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients Allergy 63 226 232 1:STN:280:DC%2BD1c%2FitlGqsA%3D%3D 18186813
25. LM Webb P Lieberman 2006 Anaphylaxis: a review of 601 cases Ann Allergy Asthma Immunol 97 39 43 16892779
26. AM Ditto KE Harris J Krasnick, et al. 1996 Idiopathic anaphylaxis: a series of 335 cases Ann Allergy Asthma Immunol 77 285 291 1:STN:280: DyaK2s%2FktVCqsA%3D%3D 8885805
27. C Akin DD Metcalfe 2003 Occult bone marrow mastocytosis presenting as recurrent systemic anaphylaxis [abstract] J Allergy Clin Immunol 111 S206 10.1016/S0091-6749(03)80711-X
28. C Akin LM Scott CN Kocabas, et al. 2007 Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis Blood 110 2331 2333 10.1182/blood-2006-06- 028100 1:CAS:528:DC%2BD2sXhtFCnsbzF 17638853 This was a systematic, prospective study designed to investigate clonal mast cell disease in patients with idiopathic anaphylaxis (Pubitemid 47523152)
29. D Ludolph-Hauser F Rueff C Fries, et al. 2001 Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings Lancet 357 361 362 10.1016/S0140-6736(00)03647-3 1:CAS:528:DC%2BD3MXhtFaktrw%3D 11211002 (Pubitemid 32128546)
30. G Haeberli M Bronnimann T Hunziker U Muller 2003 Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy Clin Exp Allergy 33 1216 1220 10.1046/j.1365-2222.2003.01755.x 1:CAS:528:DC%2BD3sXotFahur0%3D 12956741 (Pubitemid 37108524)
31. F Rueff M Placzek B Przybilla 2006 Mastocytosis and Hymenoptera venom allergy Curr Opin Allergy Clin Immunol 6 284 288 10.1097/01.all.0000235903. 10548.63 16825870 (Pubitemid 44510186)
32. K Sonneck S Florian L Mullauer, et al. 2007 This was a description of monoclonal mast cell activation syndrome Int Arch Allergy Immunol 142 158 164 10.1159/000096442 17057414 (Pubitemid 46095928)
33. P Bonadonna O Perbellini G Passalacqua, et al. 2009 Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels J Allergy Clin Immunol 123 680 686 10.1016/j.jaci.2008.11.018 1:CAS:528:DC%2BD1MXjtFKqurg%3D 19135713 This study systematically analyzed markers of clonal mast cell disease in venom anaphylaxis and found that all patients with elevated tryptase levels had a form of mast cell disease
34. P Bonadonna R Zanotti M Pagani, et al. 2009 How much specific is the association between hymenoptera venom allergy and mastocytosis? Allergy 64 1379 1382 10.1111/j.1398-9995.2009.02108.x 1:CAS:528:DC%2BD1MXhtF2jt7bO 19627274
35. SI Hungness AM Singer C Akin 2007 Food-dependent exercise-induced anaphylaxis associated with clonal mast cells carrying an activating c-kit mutation J Allergy Clin Immunol 119 S29 10.1016/j.jaci.2006.11.132
36. TJ Lin EY Bissonnette A Hirsh AD Befus 1996 Stem cell factor potentiates histamine secretion by multiple mechanisms, but does not affect tumour necrosis factor-alpha release from rat mast cells Immunology 89 301 307 10.1046/j.1365-2567.1996.d01-733.x 1:CAS:528:DyaK28Xmt1KhsLw%3D 8943730
37. A Koterba C Akin 2008 Differences in the clinical presentation of anaphylaxis in patients with indolent systemic mastocytosis versus idiopathic anaphylaxis [abstract] J Allergy Clin Immunol 121 S68 10.1016/j.jaci.2007.12.273
38. JN Oude Elberink JG de Monchy JW Kors, et al. 1997 Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis J Allergy Clin Immunol 99 153 154 1:STN:280:DyaK2s7ls1yntg%3D%3D 9003225
39. D Gonzalez de Olano I Alvarez-Twose MI Esteban-Lopez, et al. 2008 Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis J Allergy Clin Immunol 121 519 526 10.1016/j.jaci.2007.11.010 18177694 The study reports on valuable clinical experience in the management of patients with venom anaphylaxis